NIH Approved Institutional Biosafety Committee (IBC) Meeting Scheduled for January 14
In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA complies with NIH guidelines.
NIH IBC Meeting Scheduled for January 14 @ MiraVista
The meeting of the NIH approved IBC (Institutional Biosafety Committee) is scheduled for Monday, January 14, 2019 at 1:30 p.m. ET at MiraVista Diagnostics’ laboratory in Indianapolis, Indiana. Minutes from the committee meeting will be provided upon request once they are available. Please email requests to: email@example.com